Hem › Hemofili B › Kalifornien
Kliniska studier för Hemofili B i Kalifornien
7 studier för Hemofili B söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
Officiell studietext (engelska)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- och 3 fler
RekryterarFas 3
Ålder 18 och äldre · Män · Uppdaterad 2 okt. 2026 · NCT05568719Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Center for Inherited Blood Disorders, Orange
RekryterarFas 3
138 Months – 206 Months · Män · Uppdaterad 16 sep. 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Orthopaedic Hemophilia Treatment Center, Los Angeles
- David Geffen School of Medicine at UCLA, Los Angeles
- Children's Hospital Los Angeles, Los Angeles
- och 2 fler
RekryterarFas 1/2
Ålder 2 och äldre · Män · Uppdaterad 11 sep. 2026 · NCT06379789Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- University of California, San Diego (UCSD), San Diego
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 27 aug. 2026 · NCT06003387ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- och 5 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Children's Hospital Los Angeles, Los Angeles
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 60 · Alla kön · Uppdaterad 2 juli 2026 · NCT06349473SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Orthopaedic Institute for Children, Los Angeles
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
RekryterarFas 4
Ålder 12 till 100 · Alla kön · Uppdaterad 12 jan. 2026 · NCT04647227Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.